Mayo Clinic Advanced Fellowship in Multiple Myeloma, Light chain amyloidosis and Dysproteinemias

This position is for any hematologist or hematologist-oncologist looking to build a career focused on plasma cell disorders, including multiple myeloma, AL amyloidosis, Waldenström's macroglobulinemia, and other monoclonal gammopathies, beginning July 1, 2027. Fellows will gain comprehensive experience across the spectrum of plasma cell disorders, including newly diagnosed and relapsed/refractory multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, light-chain (AL) amyloidosis, and other monoclonal gammopathies and plasma cell neoplasms. Clinical training will include exposure to contemporary and emerging therapies, including novel targeted and immune-based therapies, autologous stem cell transplantation, bispecific antibodies, chimeric antigen receptor (CAR) T-cell therapy, and investigational approaches available through clinical trials. A major emphasis of the fellowship is the development of clinical investigation skills via dedicated research time. Fellows will be integrated into a mentored research project and will gain experience in study design, data analysis and interpretation, scientific presentation, and manuscript preparation and submission. Depending on the fellow’s interests, opportunities may include clinical trials, translational research, outcomes research, biomarker studies, and projects utilizing Mayo Clinic’s extensive clinical and research resources in plasma cell disorders. The goal of the fellowship is to prepare physicians for careers as academic leaders in multiple myeloma and plasma cell disorders, with expertise spanning state-of-the-art clinical care, clinical investigation, and the development of new therapeutic strategies. It will provide a unique opportunity to gain specialized clinical and research training while positioning yourself for a successful academic career in one of the most rapidly evolving areas of hematology. 🔬 What makes this fellowship unique? ✅ Direct mentorship from internationally recognized leaders in myeloma, amyloidosis, and Waldenström's macroglobulinemia. ✅ Extensive exposure to complex and rare plasma cell disorders within one of the world's largest dysproteinemia practices. ✅ Dedicated protected research time to develop an academic niche, generate publications, present at national meetings, and build a competitive academic portfolio. ✅ Robust experience in clinical trials, translational research, and the application of cutting-edge laboratory technologies to patient care. ✅ Time and mentorship specifically devoted to identifying and securing academic faculty positions, including institutions that sponsor employment-based visas and physician waivers. 📈 A proven pathway to academic success Over the past 12 years, we have trained 26 fellows. Almost every graduate has pursued an academic career, and we have successfully helped them secure a faculty position in the field of plasma cell disorders, with many now serving as myeloma and plasma cell disorder specialists at leading academic medical centers across the globe. 🌎 International applicants are encouraged to apply. Applicants should have completed appropriate hematology and/or oncology training and have successfully completed USMLE Step 1 and Step 2 examinations. Visa sponsorship opportunities are available for qualified candidates. Several of the prior graduates were international applicants who completed this program and have either secured faculty positions in the United States or Internationally. 🏡 Rochester, MN offers an outstanding quality of life with affordable living, a family-friendly community, and the opportunity to train at a world-class institution while maintaining an excellent work-life balance. Plasma cell disorders continue to undergo remarkable therapeutic advances. If you are interested in becoming part of the next generation of leaders in this field, we would love to hear from you.

About the Employer

Mayo Clinic has a longstanding international reputation for excellence in the diagnosis, treatment, and investigation of multiple myeloma and related plasma cell disorders. The program provides care for a large and diverse population of patients across the disease spectrum and offers access to an extensive portfolio of investigator-initiated and multicenter clinical trials. Fellows benefit from close interaction with an experienced multidisciplinary faculty and from Mayo Clinic’s integrated clinical practice, education, and research environment. The breadth of the clinical program, together with expertise in hematopoietic stem cell transplantation, cellular therapy, immunotherapy, laboratory investigation, and clinical trials, provides an exceptional setting for advanced training in plasma cell disorders. How to Apply

How to Apply

Applicants should have completed appropriate hematology and/or oncology training and have successfully completed USMLE Step 1 and Step 2 examinations. All applications are submitted online via the hyperlink in this post. Any inquiries should be directed to Dr. Wilson Gonsalves, MD

Contact Information

Wilson Gonsalves MD
200 First Street SW
Rochester, MN 55905 USA
https://college.mayo.edu/academics/residencies-and-fellowships/advanced-hematology-fellowship-minnesota/
gonsalves.wilson@mayo.edu